Evolution of the Average Target: Valneva SE

Evolution of the Target Price: Valneva SE

Changes in Analyst Recommendations: Valneva SE

0c5dcd604d8bc550cf9.suUuAC8bYbUVrzAEPHs3xZ8D9YG0hCrByh53lGjDQMo.y5AdZx58JYxjx1VRCxFUhtlUgu3w13K7kCw69i_wAYiGg2pUHlBR92fEAA~6855b98e39d61cc1f1f8acf53a82d388
08-11 TD Cowen Initiates Valneva at Buy Rating, With $12 Price Target MT
05-13 French Analyst Ratings: Aramis and Valneva penalized following profit warnings Zonebourse
04-30 Schneider Electric, Capgemini, Societe Generale... stocks to watch today in Paris Zonebourse
04-22 Goldman Sachs Downgrades Valneva to Sell From Neutral, Adjusts Price Target to $4.90 From $7.50 MT
04-22 French Analyst Ratings: Thales, Vallourec and Valneva in the Spotlight Zonebourse
03-18 Valneva heads for fourth consecutive gain following annual results Zonebourse
01-20 Stifel Reiterates Buy Rating and Price Target on Valneva Zonebourse
01-06 Valneva, Biggest Gainer on SBF 120 and SRD at Close of Tuesday, January 6, 2026 Zonebourse
01-06 Valneva Surges on Positive Broker Comments Zonebourse
01-06 CAC 40 Lags Behind; Valneva in Demand Zonebourse
01-06 Valneva Posts Strongest Midday Gain on SBF 120, Tuesday, January 6, 2026 Zonebourse
01-06 Stock of the Day in Paris – Valneva Bolstered by Stifel Zonebourse
01-06 Stifel Raises Price Target for Valneva Zonebourse
01-06 Analysts' calls of the day: Bernstein favors Thales over BAE Systems and Dassault Aviation Zonebourse
11-20 Stifel Reiterates Buy Recommendation on Valneva Zonebourse
11-04 Valneva SE Announces Positive Results of Its Phase 1 Clinical Trial Investigating the Safety and Immunogenicity of VLA1601 CI
25-09-03 Valneva publishes positive data for its Lyme disease vaccine candidate, stock rises RE
25-08-26 Valneva: Stifel Adjusts Price Target Following FDA Suspension of Ixchiq License Zonebourse
25-08-26 Valneva: Stifel adjusts target price Zonebourse
25-08-12 Valneva: Oddo BHF confirms 'outperform' rating Zonebourse
25-07-14 Valneva Shares Surge After EMA Lifts Restriction on Chikungunya Vaccine RE
24-08-13 Valneva: Oddo BHF confirms its recommendation on the stock Zonebourse
24-06-24 Valneva rises after Canadian approval for its chikungunya vaccine RE
24-02-05 Valneva: Oddo BHF confirms its recommendation on the stock Zonebourse
24-01-02 Valneva: Oddo BHF remains positive Zonebourse

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+144.68%
+11.79%
+27.75%
+21.67%
+24.6%
+11.82%
+21.07%
+46.63%
+6.77%
+20.91%
Average +33.77%
Weighted average by Cap. +20.90%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
2.553EUR
Average target price
6.193EUR
Spread / Average Target
+142.57%
High Price Target
12.00EUR
Spread / Highest target
+370.04%
Low Price Target
2.150EUR
Spread / Lowest Target
-15.79%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
Global
Quality
ESG MSCI
BBB
  1. Stock Market
  2. Stocks
  3. VLA Stock
  4. Consensus Valneva SE